Ads
related to: Antibody and Antibodies
Search results
Experimental NIH Antibody Protects Children From Malaria in Clinical Trial
SciTechDaily· 9 hours agoA new study reports a single dose of a malaria antibody was 77% effective in protecting children in...
Parkinson's: New treatment may help reduce motor symptoms
Medical News Today· 2 days agoPrasinezumab, a monoclonal antibody designed to target protein clumps in the brains of people with...
Gilead gives up on $4.9B antibody as solid tumor plan unravels
FierceBiotech· 10 hours agoA $4.9 billion hole has appeared in Gilead’s pipeline. After years of setbacks, the big biotech dealt a final blow to its anti-CD47 monoclonal antibody magrolimab Thursday ...
Signs of multiple sclerosis can be detected in blood 5 years before symptoms appear, new study...
Yahoo Life· 1 week agoThe best way to do this, according to Zamecnik, may be a simple antibody test that is highly...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
FOX 23 News Albany· 2 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced...
Study finds RSV treatment Beyfortus prevents 5,800 hospitalisations in France
Euronews via Yahoo News· 13 hours agoRoughly 5,800 hospitalisations from bronchiolitis were avoided in France thanks to the new...
Radiance Biopharma to Present at LSX World Congress 2024
Digital Journal· 8 hours ago...London Time) BOSTON MA / ACCESSWIRE / April 26, 2024 / Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that Robert Brooks,...
Blood test may identify who is at risk for developing multiple sclerosis
United Press International via Yahoo News· 1 week agoIn one in 10 cases of MS, the body begins producing a distinctive set of antibodies in the blood...
Building Better Antibodies and Curbing Autoimmune Diseases
Technology Networks· 1 week agoTwo of the studies show how to enhance this process — known as affinity maturation — to lay a...
OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of...
Morningstar· 1 week agoOSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective NANTES, France, April 16, 2024 – ...
